Abraham Morgentaler
Urology · Chestnut Hill, MANPI 1679505101
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (36.1%), speaking fees and education — rather than concentrated in one kind of arrangement. Besins Healthcare Ireland Limited accounts for 82.1% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $104,719, more than ten times the $1,050 reported in 2019. Among urology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $2960.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Besins Healthcare Ireland Limited$238K
- Marius Pharmaceuticals, Inc$29K
- Acerus Pharmaceuticals Corporation$14K
- Clarus Therapeutics Inc.$4K
- Ascend Therapeutics US, LLC$2K
- Tolmar, Inc.$1K
- plus $1K from 11 others
Across 8 payments — averaging $28,993 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endo Pharmaceuticals Inc.$225K
- Urovant Sciences Inc$7K
What the payments were for
- Consulting fees$37,35013%
- Speaking & faculty fees$77,67727%
- Grants$104,68436%
- Travel & lodging$18,3766%
- Food & beverage$2,0451%
- Education$50,01617%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Besins Healthcare Ireland Limited | 12 | $238,297 |
| Marius Pharmaceuticals, Inc | 2 | $29,000 |
| Acerus Pharmaceuticals Corporation | 17 | $13,967 |
| Clarus Therapeutics Inc. | 6 | $4,490 |
| Ascend Therapeutics US, LLC | 2 | $2,000 |
| Tolmar, Inc. | 2 | $1,036 |
| Antares Pharma, Inc. | 12 | $370 |
| Metuchen Pharmaceuticals | 7 | $203 |
| Aytu Biopharma, Inc. | 11 | $161 |
| Astellas Pharma US Inc | 8 | $136 |
| Endo Pharmaceuticals Inc. | 7 | $127 |
| Johnson & Johnson | 1 | $124 |
| Amgen | 6 | $122 |
| Bardy Diagnostics, Inc. | 2 | $40 |
| Sun Pharmaceutical Industries Inc. | 1 | $26 |
| Boston Scientific | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$290,147 in reported general payments places this provider in the 95th percentile of 327 urology providers in Massachusetts.
Other urology in Chestnut Hill
- William ConnersChestnut Hill$12K
- Christopher CutieBoston$3.5M
- Brian EisnerBoston$424K
- David StaskinBrighton$407K
- Liam HurleyNorth Andover$319K
- Stephen DretlerBoston$298K
- Louis LiouCambridge$278K
- Tony LuongoBoston$265K
- Ricardo MunarrizBoston$118K
- Andrew KramerHyannis$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.